Home›Stock Screener›Hester Biosciences›Quarterly Results

Hester Biosciences Quarterly Results

Latest Quarter Net Profit
₹21 Cr
QSept 2026
Quarterly Results

Hester Biosciences quarterly results. In Sept 2026, Hester Biosciences (HESTERBIO) reported revenue ₹102 Cr and net profit ₹21 Cr — revenue +22.9% YoY. View HESTERBIO 52-week high low for the annual high/low range and current price position.

HESTERBIO Quarterly Results — Revenue, Profit & EPS Highlights

Hester Biosciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Hester Biosciences stock price NSE.

  • Revenue of ₹102 Cr in Sept 2026 (+0.0% vs Mar 2026, +22.9% vs Sept 2025)
  • Net Profit of ₹21 Cr in Sept 2026 (+23.5% vs Mar 2026, +50.0% vs Sept 2025)
  • EBITDA of ₹37 Cr in Sept 2026 (+2.8% vs Mar 2026)
  • Operating Margin of 33.0% in Sept 2026 (-1.0pp vs Mar 2026)
  • Earnings Per Share of ₹23.94 in Sept 2026 (+23.1% vs Mar 2026)

Hester Biosciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

HESTERBIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 102 102 166 83 76 - 22.9%
Net Profit (₹ Cr) 21 17 97 14 2 - -
EBITDA (₹ Cr) 37 36 112 24 14 - -
EPS (₹) 23.94 19.45 113.71 16.85 1.82 - -
Operating Margin (%) 33.0% 34.0% 29.0% 17.0% 23.0% - -

HESTERBIO Share Price Trend — 1-Year Movement Across Quarterly Results

Hester Biosciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore HESTERBIO share price history to track price trends across different timeframes.

Profitability Ratios

Profit Margin 20.6%
EBITDA Margin 36.3%
Operating Margin 33.0%
ROE (Annual) 22.8%

Balance Sheet Highlights

Total Assets ₹678 Cr
Total Equity ₹368 Cr
Current Assets ₹ Cr
Current Liabilities ₹158 Cr

Cash Flow Analysis

Operating Cash Flow ₹64 Cr
Investing Cash Flow ₹-18 Cr
Financing Cash Flow ₹-49 Cr
Net Cash Flow ₹-3 Cr

Current Market Data

Current Price ₹2352.10
Exchange NSE
Last Updated Nov 19, 2026

HESTERBIO vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Hester Biosciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores